YouTube video by Hulu

YouTube video by Hulu

$YCBD 🚀 Trump EO incoming: Reclassify weed to Schedule III (less dangerous, like painkillers)! Eases penalties, cuts taxes, unlocks funding for cannabis firms. 📈 , vol 296M (75x avg). Bulls smash $1.45 today—$2 on deck? 🔥 #Webull SS + 4H below. #YCBD #Cannabis #Trump NFA 📊☕️ https://t.co/MR7JZGw0lE

YouTube video by Hulu

YouTube video by Watch What Happens Live with Andy Cohen

Reserveage, a Twinlab brand included in cbdMD (YCBD)'s proposed acquisition, launched Longev+ exclusively at The Vitamin Shoppe. The supplement is available in 20-count Mixed Berry stick packs and combines essential amino acids, HMB, creatine and resveratrol. Reserveage markets it to adults interested in muscle health and everyday performance as part of a healthy-aging routine.Reserveage is among the Twinlab brands covered by cbdMD's previously announced definitive asset purchase agreement. The proposed acquisition remains subject to court approval and customary closing conditions.

Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.

Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.

Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.

Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.

Click to view the official SEC document.

cbdMD (YCBD) entered a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea, through an assignment for the benefit of creditors process, subject to court approval and customary closing conditions.The companies report that combined unaudited trailing twelve‑month revenue ending June 2026 is approximately $30 million, which would be about 40% higher than cbdMD’s standalone revenue for the same period. The incremental revenue is expected to provide positive contribution after transaction and integration costs, although the combined figure is illustrative and not guidance.The deal is intended to give Twinlab’s brands a stable home and an orderly path for legacy obligations, keeping products available to customers, retailers, and distribution partners. cbdMD expects the acquisition to reduce its revenue concentration in hemp and mitigate risks from the evolving hemp regulatory environment while expanding into supplements, sports nutrition, beauty, weight management, longevity, and broader consumer wellness. Twinlab adds a long‑standing presence across vitamins, minerals, active lifestyle and performance nutrition, including access to 50,000 retail outlets such as Vitamin Shop and GNC and a strong Amazon presence.

Agreement will add iconic supplement brands to cbdMD's growing multi-brand consumer wellness platform, anticipated to increase revenues to approximately $30 million. CHARLOTTE, N.C., Sept. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading consumer wellness company,...

cbdMD (NYSE American: YCBD) reported third fiscal quarter 2026 net sales of $5.6 million, up 20% year-over-year, driven by a 61% increase in wholesale net sales, expanding Oasis beverage distribution, and the first full-quarter contribution of over $0.5 million from Bluebird Botanicals.Direct-to-consumer sales were $3.9 million (70% of revenue), up about 9%, while wholesale reached $1.7 million (30% of revenue). Gross margin declined to from 61.5%, and loss from operations widened to about $1.13 million. However, non-GAAP Adjusted EBITDA loss improved to approximately $508,000. Net loss attributable to common shareholders was about $1.2 million, or $0.11 per share, versus $0.21 per share a year earlier.For the first nine months of fiscal 2026, net sales rose 12% to $16.2 million and net loss attributable to common shareholders improved to about $2.4 million. According to cbdMD, cost-reduction actions initiated in July target $100,000–$150,000 in monthly savings as the company prepares for pending U.S. hemp regulations.

U.S. and Canada callers can dial 888-880-3330; the call will cover business progress, with a webcast replay available through Aug. 13, 2027.

cbdMD (NYSE American: YCBD) reports that the Senate Appropriations Committee’s August 2 continuing resolution proposal would extend current federal rules for most naturally derived hemp products, including full-spectrum CBD, from the planned November 12 restriction date to December 11.The draft bill would still allow restrictions on certain synthetic cannabinoids not naturally produced by the Cannabis sativa L. plant to proceed on November 12. cbdMD believes its core naturally derived, full-spectrum CBD product portfolio fits within the category intended for protection. The company emphasizes that the Senate language is not yet law, as the House version lacks these hemp provisions and final approval by both chambers and the President is required.

Senate continuing resolution text released August 2 would delay the pending November federal hemp restrictions. CHARLOTTE, N.C., Aug. 3, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading and trusted manufacturer and distributor of hemp-derived cannabidiol (CBD) products...

cbdMD (NYSE American: YCBD) announced its support for the bipartisan Lawful Hemp Protection Act introduced on July 21, 2026 by Reps. Andy Barr and Angie Craig. The bill seeks a long-term federal framework for hemp-derived products and would repeal a November 12, 2026 narrowing of the federal hemp definition under Section 781 of the FY 2026 appropriations law.The proposed act would place hemp-derived products under FDA oversight, require third-party testing and accurate labeling, set 21-and-over age limits, mandate domestic sourcing, and restrict synthetic intoxicating cannabinoids. cbdMD also backs the Administration and Office of Management and Budget’s calls to revise the hemp definition through budget legislation.

Company backs the Barr-Craig framework and the administration's call to fix the federal hemp definition before the November deadline CHARLOTTE, N.C., July 24, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leader in hemp-derived wellness, today announced its support for the...

cbdMD (NYSE American: YCBD) announced that its Oasis line of hemp-derived beverages is now available across South Carolina through a new distribution agreement with Morales Beverage Group, a statewide alcohol distributor. The deal places Oasis products on liquor store shelves, including at Frugal MacDoogal.The rollout covers the full Oasis portfolio and highlights the new zero-proof, spirit-style Mixer, positioned for cocktails and mixed drinks. According to cbdMD, placing Oasis within established liquor retail channels supports its strategy to reach adult consumers in familiar environments and expand hemp-derived beverage accessibility over time.

Partnership reinforces Bluebird Botanicals' Colorado roots, environmental values, and commitment to responsible growth under cbdMD leadership CHARLOTTE, N.C., July 9, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD) through its Bluebird Botanicals brand ("Bluebird"), today announced...

Bluebird will give 1% of profits from product sales over three months this summer to Denver Audubon, which protects birds and habitat in Colorado.